A high cardiothoracic ratio increases the risk of severe pulmonary complications after early initiation of clazosentan in patients with aneurysmal subarachnoid hemorrhage

Objective: Pulmonary complications, which are occasionally severe, are common adverse events following the administration of clazosentan. This study aimed to identify factors associated with severe pulmonary adverse events due to clazosentan after aneurysmal subarachnoid hemorrhage (aSAH). Methods:...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Rikuo Nishii, Tsuyoshi Ohta, Nobuyuki Fukui, Masaomi Koyanagi, Masanori Goto, Junichi Takeda, Ryu Fukumitsu, Tadashi Sunohara, Yuki Takano, Kunimasa Teranishi, Kota Nakajima, Yuji Naramoto, Yasuhiro Yamamoto, Satohiro Kawade, Ryo Sakisuka, Takateru Takamatsu, Masanori Tokuda, Hikari Tomita, Mai Yoshimoto, Nobuyuki Sakai
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	KeAi Communications Co., Ltd. 2024-04-01
Edice:	Brain Hemorrhages
Témata:	Aneurysmal subarachnoid hemorrhage Cardiothoracic ratio Pulmonary complications
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2589238X23000517
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!